Fig. 2.
![Fig. 2. Individual lymphocyte counts of responders and nonresponders. / Individual lymphocyte counts before, during, and 1 to 3 months after the end of treatment for the 7 patients with partial response (NCI criteria) (A) and the 22 nonresponders (B). (Patient no. 16, who died on the first day of treatment with a pretreatment lymphocyte count of 274.0 × 109/L [274.0/nL], is not included.)](https://ash.silverchair-cdn.com/ash/content_public/journal/blood/98/5/10.1182_blood.v98.5.1326/5/h81711467002.jpeg?Expires=1742736381&Signature=kBOQ8apa~ueklkMW4tiYu~VHxfeBLhPk1p79oGXgbPmNVlAtjvQQTMerdTThYjCmSyFkvfo7UiV73W~wPoOK74cAtYx1r5UhXCfRjQkcQYnSCyaZWoEJ8Gd7ngp1QYmFTrQSbpMCNiLIx3f22m5Aku2GogSCL0elbJdQFHxMkC9vezThDfgPcgyYNomiKzRYhHEIaKhO3RSJeaDF9CGAudhExDHjmoL7wNZunNvylSVVOAqBwNx7nsJxfCBvMm-A41CzNHIGMlCnIWLPb9f29Cr6dDqps6IfLY2b94XHwj-jfxbrlOyO80Ha-v3XrxG41eqtrNGTMOblZExle25-GQ__&Key-Pair-Id=APKAIE5G5CRDK6RD3PGA)
Individual lymphocyte counts of responders and nonresponders.
Individual lymphocyte counts before, during, and 1 to 3 months after the end of treatment for the 7 patients with partial response (NCI criteria) (A) and the 22 nonresponders (B). (Patient no. 16, who died on the first day of treatment with a pretreatment lymphocyte count of 274.0 × 109/L [274.0/nL], is not included.)
